Effects of sequestration on signal transduction cascades. 2006

Nils Blüthgen, and Frank J Bruggeman, and Stefan Legewie, and Hanspeter Herzel, and Hans V Westerhoff, and Boris N Kholodenko
Institute for Theoretical Biology, Humboldt University Berlin, Germany. nils@itb.biologie.hu-berlin.de

The building blocks of most signal transduction pathways are pairs of enzymes, such as kinases and phosphatases, that control the activity of protein targets by covalent modification. It has previously been shown [Goldbeter A & Koshland DE (1981) Proc Natl Acad Sci USA 78, 6840-6844] that these systems can be highly sensitive to changes in stimuli if their catalysing enzymes are saturated with their target protein substrates. This mechanism, termed zero-order ultrasensitivity, may set thresholds that filter out subthreshold stimuli. Experimental data on protein abundance suggest that the enzymes and their target proteins are present in comparable concentrations. Under these conditions a large fraction of the target protein may be sequestrated by the enzymes. This causes a reduction in ultrasensitivity so that the proposed mechanism is unlikely to account for ultrasensitivity under the conditions present in most in vivo signalling cascades. Furthermore, we show that sequestration changes the dynamics of a covalent modification cycle and may account for signal termination and a sign-sensitive delay. Finally, we analyse the effect of sequestration on the dynamics of a complex signal transduction cascade: the mitogen-activated protein kinase (MAPK) cascade with negative feedback. We show that sequestration limits ultrasensitivity in this cascade and may thereby abolish the potential for oscillations induced by negative feedback.

UI MeSH Term Description Entries
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D020935 MAP Kinase Signaling System An intracellular signaling system involving the mitogen-activated protein kinase cascades (three-membered protein kinase cascades). Various upstream activators, which act in response to extracellular stimuli, trigger the cascades by activating the first member of a cascade, MAP KINASE KINASE KINASES; (MAPKKKs). Activated MAPKKKs phosphorylate MITOGEN-ACTIVATED PROTEIN KINASE KINASES which in turn phosphorylate the MITOGEN-ACTIVATED PROTEIN KINASES; (MAPKs). The MAPKs then act on various downstream targets to affect gene expression. In mammals, there are several distinct MAP kinase pathways including the ERK (extracellular signal-regulated kinase) pathway, the SAPK/JNK (stress-activated protein kinase/c-jun kinase) pathway, and the p38 kinase pathway. There is some sharing of components among the pathways depending on which stimulus originates activation of the cascade. MAP Kinase Cascade,MAP Kinase Module,MAP Kinase Signaling Cascade,MAP Kinase Signaling Pathway,MAP Kinase Signaling Pathways,ERK Pathway,ERK Signal Tranduction Pathway,ERK1 and ERK2 Pathway,ERK1-2 Pathway,JNK Pathway,JNK Signaling Pathway,MAP Kinase Modules,MAP Kinase Signaling Cascades,MEK-ERK Pathway,p38 Kinase Pathway,p38 Kinase Signaling Pathway,Cascade, MAP Kinase,ERK Pathways,ERK1 2 Pathway,ERK1-2 Pathways,JNK Pathways,JNK Signaling Pathways,Kinase Cascade, MAP,Kinase Pathway, p38,Kinase Pathways, p38,MAP Kinase Cascades,MEK ERK Pathway,MEK-ERK Pathways,Module, MAP Kinase,Pathway, ERK,Pathway, ERK1-2,Pathway, JNK,Pathway, JNK Signaling,Pathway, MEK-ERK,Pathway, p38 Kinase,Pathways, ERK,Pathways, ERK1-2,Pathways, JNK,Pathways, JNK Signaling,Pathways, MEK-ERK,Pathways, p38 Kinase,Signaling Pathway, JNK,Signaling Pathways, JNK,p38 Kinase Pathways

Related Publications

Nils Blüthgen, and Frank J Bruggeman, and Stefan Legewie, and Hanspeter Herzel, and Hans V Westerhoff, and Boris N Kholodenko
November 2006, IUBMB life,
Nils Blüthgen, and Frank J Bruggeman, and Stefan Legewie, and Hanspeter Herzel, and Hans V Westerhoff, and Boris N Kholodenko
August 1998, Journal of the American Society of Nephrology : JASN,
Nils Blüthgen, and Frank J Bruggeman, and Stefan Legewie, and Hanspeter Herzel, and Hans V Westerhoff, and Boris N Kholodenko
November 2019, Emerging topics in life sciences,
Nils Blüthgen, and Frank J Bruggeman, and Stefan Legewie, and Hanspeter Herzel, and Hans V Westerhoff, and Boris N Kholodenko
January 1998, Advances in cancer research,
Nils Blüthgen, and Frank J Bruggeman, and Stefan Legewie, and Hanspeter Herzel, and Hans V Westerhoff, and Boris N Kholodenko
July 1997, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
Nils Blüthgen, and Frank J Bruggeman, and Stefan Legewie, and Hanspeter Herzel, and Hans V Westerhoff, and Boris N Kholodenko
May 1998, Molecular and cellular biochemistry,
Nils Blüthgen, and Frank J Bruggeman, and Stefan Legewie, and Hanspeter Herzel, and Hans V Westerhoff, and Boris N Kholodenko
January 2016, Frontiers in plant science,
Nils Blüthgen, and Frank J Bruggeman, and Stefan Legewie, and Hanspeter Herzel, and Hans V Westerhoff, and Boris N Kholodenko
October 1991, The Journal of steroid biochemistry and molecular biology,
Nils Blüthgen, and Frank J Bruggeman, and Stefan Legewie, and Hanspeter Herzel, and Hans V Westerhoff, and Boris N Kholodenko
June 2002, Journal of plant research,
Nils Blüthgen, and Frank J Bruggeman, and Stefan Legewie, and Hanspeter Herzel, and Hans V Westerhoff, and Boris N Kholodenko
November 2007, Thrombosis and haemostasis,
Copied contents to your clipboard!